Sterling Capital Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.8K Sell
225
-132
-37% -$2.48K ﹤0.01% 2645
2026
Q1
$6.24K Sell
357
-265
-43% -$5.26K ﹤0.01% 2623
2025
Q4
$12.2K Sell
622
-137
-18% -$2.84K ﹤0.01% 2505
2025
Q3
$20.9K Buy
759
+453
+148% +$13.9K ﹤0.01% 2114
2025
Q2
$9.34K Buy
306
+109
+55% +$3.1K ﹤0.01% 2172
2025
Q1
$5.31K Sell
197
-169
-46% -$5.35K ﹤0.01% 2142
2024
Q4
$13.1K Buy
366
+326
+815% +$12.2K ﹤0.01% 2034
2024
Q3
$1.52K Buy
+40
New +$1.64K ﹤0.01% 2331
2014
Q3
Sell
-38,920
Closed -$1.52M 960
2014
Q2
$1.52M Buy
38,920
+898
+2% +$33.3K 0.01% 460
2014
Q1
$1.43M Buy
+38,022
New +$1.33M 0.01% 470
2013
Q3
Sell
-8,592
Closed -$311K 706
2013
Q2
$311K Buy
+8,592
New +$261K ﹤0.01% 486

Other funds holding USNA

Sterling Capital Management's USNA Position: Q2 2026 in Review

Sterling Capital Management reduced its Usana Health Sciences (USNA) stake by 37% in Q2 2026, selling an estimated $2.48K and leaving 225 shares worth $4.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

Sterling Capital Management first reported a position in USNA in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.52M in Q2 2014. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Sterling Capital Management held 225 shares of Usana Health Sciences worth $4.8K as of Q2 2026.
  • Sterling Capital Management sold 132 Usana Health Sciences shares in Q2 2026, an estimated $2.48K.
  • Usana Health Sciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2645 holding.
  • Sterling Capital Management first reported a position in Usana Health Sciences in Q2 2013 and has held it in 11 quarters since.
  • Sterling Capital Management's Usana Health Sciences position peaked at $1.52M in Q2 2014.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.